Navigation and service

BIENNIAL REPORT 2019/2020

Welcome

Welcome

Research

Research

International

International

Regulation

Regulation

Organisation

Organisation

Data & Facts

Data & Facts

08.04.2020 back forward

Convalescent Plasma: First Clinical Trial

Plasma infusion (Source: sfam photo / Shutterstock)

Convalescent plasma is a potential option for treating patients suffering from severe COVID-19. The efficacy of this therapy can, however, only be proven by controlled clinical trials. The Paul-Ehrlich-Institut issues a statement calling for this and on 8 April 2020 approves the first phase I COVID-19 therapy study with convalescent plasma.

COVID-19: Plasma from Recovered Patients